You just read:

Bioniz Therapeutics Initiates Phase 1/2 Clinical Study of BNZ‑1 in T-Cell Leukemia and Lymphoma

News provided by

Bioniz Therapeutics, Inc.

Apr 04, 2018, 08:00 ET